Indivior PLC (LON:INDV – Get Free Report) shares passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 1,238 and traded as high as GBX 1,264. Indivior shares last traded at GBX 1,238, with a volume of 8,457,898 shares traded.
Indivior Stock Performance
The company’s 50-day moving average is GBX 1,238 and its 200 day moving average is GBX 1,187.35. The firm has a market cap of £1.93 billion, a PE ratio of -1,026.48, a P/E/G ratio of -5.57 and a beta of 0.19. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06.
Indivior Company Profile
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.
Featured Articles
- Five stocks we like better than Indivior
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Why Amazon Could Be a $300 Stock Within Weeks
- With Risk Tolerance, One Size Does Not Fit All
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
- The 3 Best Retail Stocks to Shop for in August
- MarketBeat Week in Review – 12/8 – 12/12
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
